Key result
Worsened GLS after pacemaker implantation is linked to ~10% higher 1-month sTNFR-2 levels.
Why the study?
Left ventricular dysfunction frequently develops after permanent pacemaker implantation, but its cellular mechanisms remain poorly understood.
Do specific biomarkers (miR-155, sTNFR-2, MMP-9, N-Cad, ZO-1) correlate with early left ventricular dysfunction (measured by GLS deterioration) following permanent pacemaker implantation in patients with total AV block?
Observational (n=42)
Yes
Do specific biomarkers (miR-155, sTNFR-2, MMP-9, N-Cad, ZO-1) correlate with early left ventricular dysfunction (measured by GLS deterioration) following permanent pacemaker implantation in patients with total AV block?
Elevated sTNFR-2 levels at 1 month post-pacemaker implantation may serve as an early inflammatory biomarker for subclinical left ventricular dysfunction detected by global longitudinal strain.
sTNFR-2 elevation was associated with post-pacemaker GLS decline; hypothesis-generating and requires prospective validation before clinical use.
Context: Total atrio-ventricular block is a lethal condition and is an indication of permanent pacemaker (PPM) implantation. Although PPM is lifesaving, patients frequently develop left ventricular dysfunction (LVd) which is traditionally detected with left ventricular ejection fraction (LVEF). Global longitudinal strain (GLS) may detect LVd before a decrease in LVEF. Cellular mechanisms of LVd following PPM implantation remain poorly understood. Aims: This study aimed to evaluate biomarker changes associated with the development of LVd following PPM implantation. Settings and Design: This quasi-experimental study was conducted on adult patients undergoing PPM implantation. Subjects and Methods: Echocardiography parameters and blood samples were obtained before PPM implantation (P0), at 1 month (P1) and at 3 months (P3). Patients divided into two groups (decreased GLS vs. unchanged GLS group) based on Delta P1 to P3 GLS. Biomarkers (miR-155, sTNFR-2, MMP-9, N-Cad, and ZO-1) concentration at P0 are compared to P1 and P3 between groups. Statistical Analysis Used: Data were evaluated using nonparametric and parametric tests, repeated-measures analyses, and multivariate modeling as appropriate. Results: A total of 42 patients were included. There is a significant difference of P1 sTNFR-2 concentration between decreased GLS group and unchanged GLS group (1947.75 [standard deviation (SD) 103.80] vs. 1778.01 [SD 237.16]; P : 0.003). Moreover, general linier model showed a higher concentration of sTNFR-2 in patients with GLS decreased compared to unchanged GLS, although the difference is insignificant ( P : 0.340). There was no statistically significant difference of other biomarkers in the study. Conclusion: STNFR-2 may represent an early inflammatory signal associated with relative GLS deterioration following permanent pacemaker implantation.
No takes yet. Share an insight, caveat, or question.
Laksono et al. (2026) conducted an observational in Total atrio-ventricular block (n=42). Decreased global longitudinal strain (GLS) following permanent pacemaker implantation vs. Unchanged GLS was evaluated on sTNFR-2 concentration at 1 month (p=0.003). Patients with decreased global longitudinal strain following permanent pacemaker implantation had significantly higher sTNFR-2 concentrations at 1 month compared to those with unchanged strain (1947.75 vs 1778.01 pg/mL, p=0.003).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: